GE HealthCare Technologies Inc. Common Stock (GEHC) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
GE HealthCare Technologies Inc. Common Stock (GEHC) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How GEHC Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $20.63B | 40% | 13.4% | $2.08B | $1.41B | 14.2% |
| FY 2024 | $19.67B | 41.7% | 13.3% | $1.99B | $1.35B | 15.9% |
| FY 2023 | $19.55B | 44% | 12.5% | $1.57B | $876.3M | 13.6% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring GEHC)
- ✓Live walkthrough of GEHC's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
GEHC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +4.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on GEHC today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for GEHC. Explore sector supply chains on /butterfly.
GEHC Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is GE HealthCare Technologies Inc. Common Stock (GEHC)?
In FY 2025 (10-K), GEHC converted $20.6B of revenue into a 40% gross margin, 13.4% operating margin, and $1.4B in free cash flow (6.8% FCF margin).